Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Clin Oncol. Feb 24, 2024; 15(2): 243-270
Published online Feb 24, 2024. doi: 10.5306/wjco.v15.i2.243
Figure 10
Figure 10  Chemotherapy drug analysis between the high- and low-risk groups in the The Cancer Genome Atlas cohort. A-D: Different sensitivities to axitinib (A), dasatinib (B), erlotinib (C), and gemcitabine (D) between the high- and low-risk groups; E: Scatter plots of the top 16 correlation analyses between immune cell-related genes and drug sensitivity.